TROY, Mich., Jan. 8 /PRNewswire-FirstCall/ -- Somanetics Corporation (Nasdaq: SMTS) will release its financial results for the fourth quarter and fiscal year ended November 30, 2009 before the opening of the market on Thursday, January 21, 2010. In conjunction with releasing its financial results, the Company will host a conference call that will be webcast live at 10:00 a.m. (ET) the same day.
On the conference call, Bruce Barrett, Somanetics' president and chief executive officer, and Bill Iacona, chief financial officer, will review Somanetics' financial results and provide a business outlook for fiscal 2010.
To listen to the webcast, visit the Presentations & Webcasts page in the Investor Relations section of Somanetics' website at www.somanetics.com 15 minutes prior to the event's broadcast and click on the "2009 Year-End Somanetics Corporation Conference Call" link. Interested parties unable to listen to the live call may access the archived version of the call on the Presentations & Webcasts page in the Investor Relations section of Somanetics' website for one year after the call. Windows Media Player or Real Player is required for access to the webcast and is available for downloading free of charge on the webcast page.
About Somanetics
Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets the INVOS® Cerebral/Somatic Oximeter which noninvasively provides accurate, real-time blood oxygen measurements in patients greater than 2.5 kilograms, and trend monitoring of this parameter for individuals of any weight. The INVOS System is the only commercially-available cerebral/somatic oximeter proven to improve outcomes. Surgeons, anesthesiologists and other medical professionals can use data provided by the INVOS System, in conjunction with other available data, to identify oxygen imbalances in brain or other body tissue beneath the sensor and take necessary corrective action, potentially improving patient outcomes and reducing the costs of care. The INVOS System is the clinical reference standard in cerebral/somatic oximetry, with an 11-year market track record, more than 700 clinical references and implementation at more than 700 U.S. hospitals. Somanetics also develops, manufactures and markets the Vital Sync™ System, a device that integrates data from bedside devices into a single system for enhanced patient assessment and decision making, data management and data storage. Somanetics supports its customers through a direct U.S. sales force and clinical education team. Covidien markets INVOS System products in Europe, Canada, the Middle East and South Africa and Edwards Lifesciences represents INVOS System products in Japan. For more information visit www.somanetics.com.
SOURCE Somanetics Corporation
Advertisement
On the conference call, Bruce Barrett, Somanetics' president and chief executive officer, and Bill Iacona, chief financial officer, will review Somanetics' financial results and provide a business outlook for fiscal 2010.
Advertisement
To listen to the webcast, visit the Presentations & Webcasts page in the Investor Relations section of Somanetics' website at www.somanetics.com 15 minutes prior to the event's broadcast and click on the "2009 Year-End Somanetics Corporation Conference Call" link. Interested parties unable to listen to the live call may access the archived version of the call on the Presentations & Webcasts page in the Investor Relations section of Somanetics' website for one year after the call. Windows Media Player or Real Player is required for access to the webcast and is available for downloading free of charge on the webcast page.
About Somanetics
Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets the INVOS® Cerebral/Somatic Oximeter which noninvasively provides accurate, real-time blood oxygen measurements in patients greater than 2.5 kilograms, and trend monitoring of this parameter for individuals of any weight. The INVOS System is the only commercially-available cerebral/somatic oximeter proven to improve outcomes. Surgeons, anesthesiologists and other medical professionals can use data provided by the INVOS System, in conjunction with other available data, to identify oxygen imbalances in brain or other body tissue beneath the sensor and take necessary corrective action, potentially improving patient outcomes and reducing the costs of care. The INVOS System is the clinical reference standard in cerebral/somatic oximetry, with an 11-year market track record, more than 700 clinical references and implementation at more than 700 U.S. hospitals. Somanetics also develops, manufactures and markets the Vital Sync™ System, a device that integrates data from bedside devices into a single system for enhanced patient assessment and decision making, data management and data storage. Somanetics supports its customers through a direct U.S. sales force and clinical education team. Covidien markets INVOS System products in Europe, Canada, the Middle East and South Africa and Edwards Lifesciences represents INVOS System products in Japan. For more information visit www.somanetics.com.
SOURCE Somanetics Corporation
